Table of Content


COMPANY EXECUTIVE SUMMARY 1
Table of Contents 2
Tables 6
Charts 7
Terumo Corporation - Key Company Facts 8
Terumo Corporation - Company Description 9
Terumo Corporation - Top Executives 10
Terumo Corporation- Head Office & Locations 11
Head Office - Country 11
Terumo Corporation - Products and Services 12
Products 12
Terumo Corporation - Company’s Mission and Vision 13
Vision 13
Terumo Corporation - Corporate Strategy 14
Terumo Corporation - Business Description 16
Cardiovascular Segment 17
General Hospital Segment 17
Blood Management Segment 17
Diabetes Care Segment 18
Terumo Corporation - ESG Spotlight 19
Environment 19
Social 20
Corporate Governance 20
Terumo Corporation - SWOT Analysis 21
Overview 21
Strengths 23
Weaknesses 25
Opportunities 26
Threats 28
Terumo Corporation - PESTLE Analysis 30
Overview 30
Political Factors 32
Economic Factors 35
Social Factors 37
Technological Factors 38
Legal Factors 39
Environmental Factors 41
Terumo Corporation - Financial Deep Dive 43
Share Price Trend - Oct-2023to Oct-2024 (Average Share Closing Price) 43
Profit and Loss Statement 45
Summary of Profit and Loss Statement 45
Balance Sheet 47
Summary of Balance Sheet 47
Cash Flow Statement 49
Summary of Cash Flow Statement 49
Key Financial Ratio Analysis 51
Terumo Corporation - Ratio Charts 52
Activity Ratio Charts 52
Growth Ratios Charts 53
Leverage Ratio Charts 54
Liquidity Ratio Charts 54
Profitability Ratio Charts 56
Competing Players 57
Snapshot of Competing Players 58
Becton, Dickinson and Company 58
Key Company Facts 58
Company Description 58
Snapshot of Competing Players 60
Boston Scientific Corporation 60
Key Company Facts 60
Company Description 60
Snapshot of Competing Players 62
Johnson & Johnson 62
Key Company Facts 62
Company Description 62
Snapshot of Competing Players 64
Medtronic plc 64
Key Company Facts 64
Company Description 64
Snapshot of Competing Players 66
Stryker Corporation 66
Key Company Facts 66
Company Description 66
Terumo Corporation - In the News 68
18-Sep-2024- Terumo Announces New Neurovascular Business Brand "Terumo Neuro" 68
13-Sep-2024- Terumo holds internal event "Terumo Patient’s Day 2024" 69
26-Aug-2024- Terumo launches PTCA guidewire "Runthrough NS Izanai" in Japan 70
06-Aug-2024- Terumo Establishes Corporate Venture Capital "Terumo Ventures" 71

30-Jul-2024- Terumo India Wins Big For Its Health & Wellbeing Initiatives 72
26-Jun-2024- MicroVention Announces the Next Evolution in Stent Innovation: MicroVention’s LVIS? EVO? Intraluminal Support Device Now Available in the United States MicroVention Continues to Lead the Way in Innovation for both Ischemic and Hemorrhagic Stroke Treatment and Prevention 74
19-Mar-2024- Terumo Blood and Cell Technologies partners with CiRA Foundation to develop automated iPS cell manufacturing iPS cell manufacturing organization researchers to integrate Terumo Blood and Cell Technologies’ Quantum Flex, expertise through collaboration 75
19-Feb-2024- Terumo Blood and Cell Technologies-sponsored panel publishes first-of-its-kind international consensus recommendations for pregnancy complications in patients with sickle cell disease 77
Appendix 79
Definitions 79
SWOT Analysis 79
PESTLE Analysis 79
Value Chain Analysis 79
ESG Spotlight 79
Financial Deep Dive 79
Financial Ratios - 80
Activity Ratios 80
Growth Ratios 81
Leverage Ratios 82
Liquidity Ratios 83
Market Ratios 84
Profitability Ratios 84
Research Methodology 85
Disclaimer 86
Contact Us 86



List of Figures

Charts
Figure 1: Terumo Corporation- SWOT Analysis 22
Figure 2: Terumo Corporation - PESTLE Analysis 31
Figure 3: Terumo Corporation - Average Share Price Trend - Oct-2023 to Oct-2024 44
Figure 4: Terumo Corporation - Profit and Loss Statement - 2021-2024 46
Figure 5: Terumo Corporation - Balance Sheet - 2021-2024 48
Figure 6: Terumo Corporation - Cash Flow Statement 2021-2024 50
Figure 7: Terumo Corporation - Activity Ratio Charts 52
Figure 8: Terumo Corporation - Growth Ratio Charts (Value %) 53
Figure 9: Terumo Corporation - Leverage Ratio Charts 54
Figure 10: Terumo Corporation - Liquidity Ratio Charts 55
Figure 11: Terumo Corporation - Profitability Ratio Charts (Value %) 56
Figure 12: Competing Players - Becton, Dickinson and Company - Key Financials 59
Figure 13: Competing Players - Boston Scientific Corporation - Key Financials 61
Figure 14: Competing Players - Johnson & Johnson - Key Financials 63
Figure 15: Competing Players - Medtronic plc - Key Financials 65
Figure 16: Competing Players - Stryker Corporation - Key Financials 67

List of Tables

Tables
Table 1: Terumo Corporation - Company Facts
Table 2: Terumo Corporation - Top Executives
Table 3: Terumo Corporation - Products
Table 4: Terumo Corporation - Share Price Trend - Oct-2023 to Oct-2024
Table 5: Terumo Corporation- Ratio Analysis - 2021-2024
Table 6: Terumo Corporation -Competing Players